Financhill
Back

ProPhase Labs Vs. OncoCyte Industry Stock Comparison

Sell
31

PRPH
ProPhase Labs

Last Price:
2.45
Seasonality Move:
20.16%
Sell
27

OCX
OncoCyte

Last Price:
3.00
Seasonality Move:
-0.82%
Sell
31
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $2.45. The Score for PRPH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.95. The Score for OCX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $2.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing selling pressure, which indicates risk of future bearish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: -38684 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.77) Sell
Bollinger Bands (100): (2.71 - 4.81) Sell

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.95 Sell
Chaikin Money Flow: -6069 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.03 - 3.17) Sell
Bollinger Bands (100): (2.74 - 3.18) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.59 Sell
20-day SMA: 2.58 Sell
50-day SMA: 2.8 Sell
200-day SMA: 4.48 Sell
8-day EMA: 2.55 Sell
20-day EMA: 2.6 Sell
50-day EMA: 2.94 Sell
200-day EMA: 4.29 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.11 Sell
20-day SMA: 3.11 Sell
50-day SMA: 3.13 Sell
200-day SMA: 2.98 Sell
8-day EMA: 3.08 Sell
20-day EMA: 3.1 Sell
50-day EMA: 3.07 Sell
200-day EMA: 3.35 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):